We are live on ! Find out more
ATRC icon

AtriCure

189 hedge funds and large institutions have $1.89B invested in AtriCure in 2020 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 71 increasing their positions, 49 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

257% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 14

56% more capital invested

Capital invested by funds: $1.21B → $1.89B (+$675M)

45% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 49

42% more call options, than puts

Call options by funds: $1.56M | Put options by funds: $1.1M

23% more funds holding

Funds holding: 154189 (+35)

5.27% more ownership

Funds ownership: 89.96%95.23% (+5.3%)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
189
Holders Change
+35
Holders Change %
+22.73%
% of All Funds
3.87%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.06%
New
50
Increased
71
Reduced
49
Closed
14
Calls
$1.56M
Puts
$1.1M
Net Calls
+$464K
Net Calls Change
-$17.9M

ATRC Hedge Fund Activity: Q2 2020 in Review

189 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2020, worth a combined $1.89B — up 56% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new ATRC positions and 14 closed out — a net gain of 36 holders — while 71 added to existing stakes and 49 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $53.3M. The largest seller was Wellington Management Group, cutting an estimated $63.1M.

  • 189 institutional investors held AtriCure (ATRC) as of Q2 2020, up from 154 in Q1 2020.
  • Funds reported $1.89B of AtriCure stock for Q2 2020, up 56% quarter-over-quarter.
  • 50 funds opened new AtriCure positions in Q2 2020 and 14 closed out, a net change of +36 holders.
  • The largest AtriCure buyer in Q2 2020 was Fidelity Investments, an estimated $53.3M added.
  • The largest AtriCure seller in Q2 2020 was Wellington Management Group, an estimated $63.1M sold.

Based on aggregated 13F filings for Q2 2020.